Phase III clincial trials for the AstraZeneca drug Tagrisso for lung cancer demonstrated overwhelming efficacy, reducing death and tumor recurrence by 89%.
The post ‘Overwhelming Efficacy’ Found in New Lung Cancer Drug – Yale PhD Calls it ‘Transformative’ appeared first on Good News Network.
Phase III clincial trials for the AstraZeneca drug Tagrisso for lung cancer demonstrated overwhelming efficacy, reducing death and tumor recurrence by 89%.
The post ‘Overwhelming Efficacy’ Found in New Lung Cancer Drug – Yale PhD Calls it ‘Transformative’ appeared first on Good News Network.